Atosiban Acetate 6.75?mg Wholesale price comparison

Description Contents hide 1 Product Specifications 2 Mechanism of Action 3 Research Applications & Pharmacology 4 Safety Profile & Handling 5 ?? Research-Use Disclaimer Product SpecificationsParameterDetailsProduct NameAtosiban Acetate Injection (Jiameidi®)Generic NameAtosiban AcetateSynonymsTractocile, Antocin, Oxytocin Receptor AntagonistCAS Number90779-69-4FormulationSterile aqueous injectionStrength6.75?mg in 0.9?mL vialPack Size1 vial per boxDosage FormIntravenous injection (research use only)Approval NumberNMPA China: H20223013Product Code86979252000116ManufacturerHainan General Kangli Pharmaceutical Co., Ltd.Barcode6930054180189AppearanceClear, colorless, particle-free solutionStorageRefrigerate at 2–8?°C; protect from lightShelf Life2 yearsIntended UseLaboratory research onlyMechanism of ActionAtosiban is a synthetic peptide oxytocin and vasopressin V1a receptor antagonist, rapidly inhibiting uterine contractions by blocking oxytocin-mediated calcium signaling in myometrial cellsResearch Applications & PharmacologyUsed in tocolytic research to study delayed labor and uterine quiescence in vitro and in vivo models .Explored for improving implantation rates in IVF through oxytocin receptor pathways .Typical protocol: bolus IV dose of 6.75?mg followed by dosage adjustment based on model needs .Safety Profile & HandlingObserved Effects:No major side effects in preclinical studies; typical human effects: nausea, headaches .Laboratory Handling:Use full lab PPE (gloves, goggles, coat).Store 2–8?°C; ensure visual clarity before use.Dispose per biohazard/universal sharps regulations.?? Research-Use DisclaimerThis product is exclusively for laboratory and preclinical research. It is not approved for therapeutic, diagnostic, clinical, or veterinary use. Misuse may pose safety risks and regulatory non-compliance.